UNSPSC 51453013: Piperazine hydrobromide

This classification denotes an antihelminthic agent with the molecular formula C4H10N2.BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V1FWC6DPTK, chemically known as piperazine, hydrobromide (1:1), but more generally known as piperazine hydrobromide, which bears US NIH Compound Identifier 3014804. European Medicines Agency schedules piperazine hydrobromide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03841MIG.

Most nations, for tariff purposes, schedule piperazine hydrobromide under HS 29335990. SMILES: C1CNCCN1.BR.

UNSPSC 51453013 Piperazine hydrobromide, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code's name suggests a specific chemical compound used in pharmaceutical manufacturing, yet the recent opportunities tagged under it involve naloxone procurement, medical and first aid supplies for emergency response, generic pharmaceuticals and OTC products through cooperative purchasing, and pharmacy benefit program strategy—none of which directly concern piperazine hydrobromide as a finished product or bulk chemical input. State and local governments procuring under this code are acquiring ready-to-use medical supplies, pharmaceutical distribution services, and health system supplies rather than chemical intermediates or active pharmaceutical ingredients in their pure form. The issuing bodies include county health departments, city fire departments, state health and human services commissions, and multistate cooperative purchasing alliances serving state and local facilities across multiple jurisdictions.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response due July 26, 2023. The City of Tampa issued ITB 26P00145 in March 2026 for medical and first aid supplies to support the Fire Department Rescue Division—169 line items ranging from cardiac monitoring electrodes to oxygen delivery systems, with an estimated contract value of $700,000, response due March 13, 2026, and a set-aside for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription fulfillment strategies outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The code shows little relevant recent activity; the disconnect between the code's chemical substance definition and the actual procurement scope suggests potential data mistagging or category-assignment issues in these solicitations.